These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 198230)

  • 1. Effect of dopamine on firing patterns on striatal units in adult and 21-day-old rats.
    Ewart WR; Williams TD
    Exp Neurol; 1977 Nov; 57(2):434-9. PubMed ID: 198230
    [No Abstract]   [Full Text] [Related]  

  • 2. Actions of papaverine and bulbocapnine on synaptic transmission in the nigro-striatal pathway in the rat.
    Gonzalez-Vegas JA
    J Physiol; 1972 Oct; 226(2):102P. PubMed ID: 4343629
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.
    Gonzalez-Vegas JA
    Brain Res; 1974 Nov; 80(2):219-28. PubMed ID: 4371023
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
    Yu H; Matsubayashi H; Amano T; Cai J; Sasa M
    Brain Res; 2000 Jul; 872(1-2):223-6. PubMed ID: 10924698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine-glutamate interactions reflected in substantia nigra reticulata firing.
    Timmerman W; Westerhof F; van der Wal TI; Westerink BH
    Neuroreport; 1998 Dec; 9(17):3829-36. PubMed ID: 9875713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
    Sanderson P; Mavoungou R; Albe-Fessard D
    Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of substance P in the nigrostriatal system.
    Borison RL; Klawans HL; Diamond BI
    Int J Neurol; 1980; 14(2-4):189-94. PubMed ID: 6194132
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra.
    Hargraves R; Freed WJ
    Life Sci; 1987 Mar; 40(10):959-66. PubMed ID: 3821366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine-induced striatal dopamine efflux depends on the activity of nigrostriatal dopamine neurones.
    Moleman P; Bruinvels J
    Nature; 1979 Oct; 281(5733):686-7. PubMed ID: 551287
    [No Abstract]   [Full Text] [Related]  

  • 15. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL; Nair NP; Bozarth M
    Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetanus toxin and synaptic inhibition in the substantia nigra and striatum of the rat.
    Davies J; Tongroach P
    J Physiol; 1979 May; 290(2):23-36. PubMed ID: 469755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat.
    Van Zwieten-Boot BJ; Noach EL
    Eur J Pharmacol; 1975; 33(2):247-54. PubMed ID: 171162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.